BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
GSHD
Goosehead Insurance, Inc
GSHD has the edge over BAC overall, supported by stronger valuation and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
GSHD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
GSHD's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like GSHD.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
GSHD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $45.66 | — |
| Current | 33x | $45.66 | — |
| Cheap | 70x | $95.30 | +109% |
| Fair | 187x | $256 | +461% |
| Expensive | 400x | $548 | +1100% |
Historical ranges are pointers, not guarantees.
GSHD has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
GSHD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for GSHD, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
GSHD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.35 | +71% |
| Q2 2026 | $1.37 | +20% |
| Q1 2026 | $1.14 | -5% |
| Q4 2025 | $1.04 | -10% |
| Q3 2025 | $1.14 | +63% |
| Q2 2025 | $1.14 | +65% |
| Q1 2025 | $1.20 | +100% |
| Q4 2024 | $1.16 | +111% |
| Q3 2024 | $0.70 | +52% |
GSHD earned $1.37 per share over the past year, up 20% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over GSHD on profitability, with a higher operating margin.
GSHD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $113.4M | +21% |
| Q1 2026 | $93.1M | +23% |
| Q4 2025 | $105.3M | +12% |
| Q3 2025 | $90.4M | +16% |
| Q2 2025 | $94M | +20% |
| Q1 2025 | $75.6M | +17% |
| Q4 2024 | $93.9M | +49% |
| Q3 2024 | $78M | +9.9% |
GSHD has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 23% | +6.8 points |
| Q1 2026 | 16% | +7.4 points |
| Q4 2025 | 29% | -0.3 points |
| Q3 2025 | 24% | +2.5 points |
| Q2 2025 | 17% | -3.1 points |
| Q1 2025 | 8.8% | +6.5 points |
| Q4 2024 | 30% | +19 points |
| Q3 2024 | 21% | +1.9 points |
GSHD's operating margin was 23% last quarter, up 6.8 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
GSHD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $14.4M | -47% |
| Q1 2026 | $21.2M | +42% |
| Q4 2025 | $20.3M | +68% |
| Q3 2025 | $23.7M | -15% |
| Q2 2025 | $27.2M | +44% |
| Q1 2025 | $14.9M | +28% |
| Q4 2024 | $12.1M | -7.3% |
| Q3 2024 | $28M | +35% |
GSHD has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
GSHD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -930K shares |
| 1 year | -7.4% | -2.8M shares |
| 3 years | +54% | +12.5M shares |
| 5 years | +94% | +17.3M shares |
| Available history | +117% | +19.3M shares |
GSHD has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $3.9M |
| Q1 2026 | $49.8M |
| Q4 2025 | $23.5M |
| Q3 2025 | $57.7M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2021 | — |
GSHD spent $135M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
GSHD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 2.9x | Moderate |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | 0.5x | Very low |
| Q3 2024 | 0.9x | Very low |
GSHD has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
GSHD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 21.4 | Neutral |
GSHD's weekly RSI is 44 (neutral) and its Stochastic is 21 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over GSHD on valuation relative to its sector.
GSHD PE vs Financial Services Sector
| Metric | GSHD | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 13x | 156% above |
| PE % | 2 | 63 | 61 pts below |
GSHD is trading at 33x earnings, a 156% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over GSHD on trend strength, trading above more of its moving averages.
GSHD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.3 | 3.4% below |
| 20 week MA | $55.6 | 18% below |
| 50 week MA | $53.7 | 15% below |
| 100 week MA | $74.9 | 39% below |
| 200 week MA | $72.9 | 37% below |
GSHD is in a downtrend: it's below all five of its weekly moving averages, and 37% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over GSHD on returns for 2026, with the stronger performance.
GSHD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.1 | $124.2 | +195% |
| 2021 | $124.2 | $138.1 | +11% |
| 2022 | $138.1 | $38.3 | -72% |
| 2023 | $38.3 | $75.8 | +98% |
| 2024 | $75.8 | $104.2 | +37% |
| 2025 | $104.2 | $75.3 | -28% |
| 2026 YTD | $75.3 | $45.7 | -39% |
GSHD's yearly returns have swung widely, from +195% in 2020 to −72% in 2022. It's down 39% so far in 2026.